Bleeding recurred within 30 days in 8 patients ( 6.7 percent ) in the omeprazole group , as compared with 27 ( 22.5 percent ) in the placebo group ( hazard ratio , 3.9 ; 95 percent confidence interval , 1.7 to 9.0 ) .
